Linked Life Data

9675762

Source:http://linkedlifedata.com/resource/pubmed/id/9675762

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9675762rdf:typepubmed:Citationlld:pubmed
pubmed-article:9675762lifeskim:mentionsumls-concept:C0019158lld:lifeskim
pubmed-article:9675762lifeskim:mentionsumls-concept:C0019196lld:lifeskim
pubmed-article:9675762lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9675762lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:9675762lifeskim:mentionsumls-concept:C0019004lld:lifeskim
pubmed-article:9675762lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:9675762lifeskim:mentionsumls-concept:C0032893lld:lifeskim
pubmed-article:9675762lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9675762lifeskim:mentionsumls-concept:C0015737lld:lifeskim
pubmed-article:9675762pubmed:issue4lld:pubmed
pubmed-article:9675762pubmed:dateCreated1998-9-1lld:pubmed
pubmed-article:9675762pubmed:abstractTextFrench and American consensus conferences on hepatitis C confirmed the burden of that disease, especially in high risk populations. In France, the seroprevalence of HCV is about 20% among haemodialysed patients. This study aimed at describing the French screening practices in haemodialysed patients. In 1995, 1213 self-administered questionnaires were sent to nephrologists working in 715 dialysis units. The response rate was 48% (585/1213) and 485 questionnaires were analysed. In 98% of questionnaires nephrologists answered that they prescribed screening test. Routine screening with alanine amino-transferase (ALT) was reported in 98% of questionnaires, usually once a month (57%) or four times a year (23%). Routine anti-HCV serology was reported by 96%, usually once (28%) or twice (46%) a year. The two main annual strategies combining ALT and anti-HCV serology were 12 ALT and 2 serologies (21%), or 12 ALT and 1 serology (14%) per year. HCV RNA detection was reported mainly in the case of positive anti-HCV serology (70%). The study suggested heterogeneity in screening practices and revealed the need to determine the cost-effectiveness ratios of the various strategies.lld:pubmed
pubmed-article:9675762pubmed:languagefrelld:pubmed
pubmed-article:9675762pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9675762pubmed:citationSubsetIMlld:pubmed
pubmed-article:9675762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9675762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9675762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9675762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9675762pubmed:statusMEDLINElld:pubmed
pubmed-article:9675762pubmed:issn0250-4960lld:pubmed
pubmed-article:9675762pubmed:authorpubmed-author:LabeeuwMMlld:pubmed
pubmed-article:9675762pubmed:authorpubmed-author:UTINAIaIalld:pubmed
pubmed-article:9675762pubmed:authorpubmed-author:LarocheCClld:pubmed
pubmed-article:9675762pubmed:authorpubmed-author:ColinCClld:pubmed
pubmed-article:9675762pubmed:authorpubmed-author:BaillyFFlld:pubmed
pubmed-article:9675762pubmed:authorpubmed-author:CailletteAAlld:pubmed
pubmed-article:9675762pubmed:authorpubmed-author:MercierSSlld:pubmed
pubmed-article:9675762pubmed:authorpubmed-author:VergnonPPlld:pubmed
pubmed-article:9675762pubmed:authorpubmed-author:DucretNNlld:pubmed
pubmed-article:9675762pubmed:issnTypePrintlld:pubmed
pubmed-article:9675762pubmed:volume19lld:pubmed
pubmed-article:9675762pubmed:ownerNLMlld:pubmed
pubmed-article:9675762pubmed:authorsCompleteYlld:pubmed
pubmed-article:9675762pubmed:pagination217-22lld:pubmed
pubmed-article:9675762pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:meshHeadingpubmed-meshheading:9675762-...lld:pubmed
pubmed-article:9675762pubmed:year1998lld:pubmed
pubmed-article:9675762pubmed:articleTitle[National study of screening practices for hepatitis C among hemodialysis patients. Hepatitis Group].lld:pubmed
pubmed-article:9675762pubmed:affiliationDépartement d'information médicale des Hospices civils de Lyon.lld:pubmed
pubmed-article:9675762pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9675762pubmed:publicationTypeEnglish Abstractlld:pubmed